ATE409864T1 - Ss3-integrin als indikator für endometriose - Google Patents
Ss3-integrin als indikator für endometrioseInfo
- Publication number
- ATE409864T1 ATE409864T1 AT03020599T AT03020599T ATE409864T1 AT E409864 T1 ATE409864 T1 AT E409864T1 AT 03020599 T AT03020599 T AT 03020599T AT 03020599 T AT03020599 T AT 03020599T AT E409864 T1 ATE409864 T1 AT E409864T1
- Authority
- AT
- Austria
- Prior art keywords
- integrin
- sample
- endometriosis
- indicator
- monitoring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
- G01N2333/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/155,435 US5478725A (en) | 1992-06-12 | 1993-11-19 | αv β3 integrin as a predictor of endometriosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE409864T1 true ATE409864T1 (de) | 2008-10-15 |
Family
ID=22555419
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95902592T ATE258058T1 (de) | 1993-11-19 | 1994-11-18 | Alphavbeta3 integrin als indikator für endometriose |
AT03020599T ATE409864T1 (de) | 1993-11-19 | 1994-11-18 | Ss3-integrin als indikator für endometriose |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95902592T ATE258058T1 (de) | 1993-11-19 | 1994-11-18 | Alphavbeta3 integrin als indikator für endometriose |
Country Status (9)
Country | Link |
---|---|
US (1) | US5478725A (de) |
EP (3) | EP0734263B1 (de) |
JP (1) | JP4155592B2 (de) |
AT (2) | ATE258058T1 (de) |
AU (1) | AU684582B2 (de) |
CA (1) | CA2176926C (de) |
DE (2) | DE69433504T2 (de) |
ES (2) | ES2312703T3 (de) |
WO (1) | WO1995013821A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733979B2 (en) | 1993-11-01 | 2004-05-11 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
US6979533B2 (en) * | 1992-06-12 | 2005-12-27 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
US5863954A (en) * | 1992-06-30 | 1999-01-26 | John B. Davidson | Contraceptive method using ajoene |
EP0754046A1 (de) * | 1994-04-04 | 1997-01-22 | FREEMAN, William R. | Verwendung der phosphonylmethoxyalkyl-nukleoside zur behandlung des erhöhten innenaugendrucks |
US5654145A (en) * | 1994-10-04 | 1997-08-05 | La Jolla Cancer Research Foundation | Trophinin and trophinin-assisting nucleic acids and methods of detection thereof |
US5599918A (en) * | 1994-10-04 | 1997-02-04 | La Jolla Cancer Research Foundation | Nucleic acids encoding trophinin and trophinin-assisting proteins |
US6743595B1 (en) | 1999-01-25 | 2004-06-01 | Metriogene Biosciences Inc. | Method and diagnostic kit for diagnosis of endometriosis |
AU4056000A (en) * | 1999-04-02 | 2000-10-23 | Center For Molecular Medicine And Immunology | Method of detecting endometriosis |
EP1801236B1 (de) * | 2000-02-25 | 2009-11-18 | Siemens Healthcare Diagnostics Inc. | Endometriose Marker und Verwendung derselben |
DE60140580D1 (de) * | 2000-02-25 | 2009-12-31 | Siemens Healthcare Diagnostics | Endometriose Marker und Verwendung derselben |
US7045663B2 (en) * | 2001-07-10 | 2006-05-16 | Billings Pharmaceuticals, Inc. | Chiral integrin modulators and methods of use thereof |
DE10048633A1 (de) * | 2000-09-25 | 2002-04-18 | Schering Ag | Methode zur in vitro Diagnostik von Endometriose |
US6780594B2 (en) * | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
CN1507354A (zh) * | 2001-03-02 | 2004-06-23 | ͨ��ҽ�ƹ�˾ | 通过给予整合蛋白αvβ3拮抗剂并与其它预防或治疗药剂配合来预防或者治疗炎性疾病或自身免疫疾病的方法 |
KR100523835B1 (ko) * | 2002-02-19 | 2005-10-25 | 주식회사 바이오인프라 | PrxⅡ 단백질을 진단 마커로 사용하여 자성 포유동물의불임을 진단하는 방법 |
JP2005525368A (ja) * | 2002-03-04 | 2005-08-25 | メディミューン,インコーポレーテッド | インテグリンαvβ3アンタゴニストをHMG−CoA還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法 |
WO2003075957A1 (en) * | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
EP1499352A4 (de) * | 2002-04-12 | 2006-10-11 | Medimmune Inc | Rekombinante anti-interleukin-9-antikörper |
US20040005612A1 (en) * | 2002-05-14 | 2004-01-08 | Giudice Linda C. | Endometrial genes in endometrial disorders |
CA2514653A1 (en) * | 2003-01-30 | 2004-08-12 | Medimmune, Inc. | Uses of integrin alphavbeta3 antagonists |
AU2004229501B2 (en) | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
WO2005008251A2 (en) * | 2003-07-11 | 2005-01-27 | Praecis Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis |
EP1737816A1 (de) * | 2004-03-10 | 2007-01-03 | Billings Pharmaceuticals, Inc. | Integrinmodulatoren und verfahren zu deren anwendung |
US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
EP2422811A2 (de) | 2004-10-27 | 2012-02-29 | MedImmune, LLC | Modulation von Antikörperspezifität mittels Anpassung der Affinität zu verwandten Antigenen |
AU2007272970C1 (en) | 2006-07-11 | 2013-01-10 | Roy C. Levitt | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
CA3177366A1 (en) | 2006-08-10 | 2008-02-21 | Roy C. Levitt | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
WO2008137591A2 (en) * | 2007-05-02 | 2008-11-13 | Biocept, Inc. | Non-invasive detection of endometrial cancer |
US7846680B2 (en) | 2008-01-29 | 2010-12-07 | Albert Einstein College Of Medicine Of Yeshiva University | Detection of the nucleolar channel system of human endometrium and uses thereof |
DE102012002929A1 (de) | 2012-02-14 | 2013-08-14 | Jürgen Lewald | Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose |
US10234465B2 (en) * | 2014-03-19 | 2019-03-19 | The University Of North Carolina At Chapel Hill | BCL6 expression in eutopic endometrium as a marker for endometriosis and subfertility |
US11474105B2 (en) | 2016-03-31 | 2022-10-18 | The University Of North Carolina At Chapel Hill | Methods and compositions for SIRT1 expression as a marker for endometriosis and subfertility |
IT201900013992A1 (it) * | 2019-08-05 | 2021-02-05 | Telea Electronic Eng Srl | Metodo per stimolare l’espressione genica in cellule endometriali |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5057604A (en) * | 1988-08-03 | 1991-10-15 | Washington University | Novel monoclonal antibodies |
US5279941A (en) * | 1992-06-12 | 1994-01-18 | Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
-
1993
- 1993-11-19 US US08/155,435 patent/US5478725A/en not_active Expired - Lifetime
-
1994
- 1994-11-18 AT AT95902592T patent/ATE258058T1/de active
- 1994-11-18 EP EP95902592A patent/EP0734263B1/de not_active Expired - Lifetime
- 1994-11-18 AT AT03020599T patent/ATE409864T1/de not_active IP Right Cessation
- 1994-11-18 EP EP08002178A patent/EP1927362A3/de not_active Withdrawn
- 1994-11-18 AU AU11809/95A patent/AU684582B2/en not_active Ceased
- 1994-11-18 EP EP03020599A patent/EP1394551B1/de not_active Expired - Lifetime
- 1994-11-18 JP JP51460395A patent/JP4155592B2/ja not_active Expired - Fee Related
- 1994-11-18 WO PCT/US1994/013299 patent/WO1995013821A1/en active IP Right Grant
- 1994-11-18 ES ES03020599T patent/ES2312703T3/es not_active Expired - Lifetime
- 1994-11-18 DE DE69433504T patent/DE69433504T2/de not_active Expired - Lifetime
- 1994-11-18 CA CA002176926A patent/CA2176926C/en not_active Expired - Fee Related
- 1994-11-18 DE DE69435147T patent/DE69435147D1/de not_active Expired - Lifetime
- 1994-11-18 ES ES95902592T patent/ES2214495T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU1180995A (en) | 1995-06-06 |
EP0734263A1 (de) | 1996-10-02 |
US5478725A (en) | 1995-12-26 |
JP4155592B2 (ja) | 2008-09-24 |
EP1394551A3 (de) | 2004-06-16 |
EP0734263B1 (de) | 2004-01-21 |
EP1927362A2 (de) | 2008-06-04 |
EP1394551B1 (de) | 2008-10-01 |
EP1927362A3 (de) | 2009-01-21 |
ES2312703T3 (es) | 2009-03-01 |
ES2214495T3 (es) | 2004-09-16 |
AU684582B2 (en) | 1997-12-18 |
DE69433504D1 (de) | 2004-02-26 |
WO1995013821A1 (en) | 1995-05-26 |
EP1394551A2 (de) | 2004-03-03 |
JPH09505569A (ja) | 1997-06-03 |
DE69435147D1 (de) | 2008-11-13 |
CA2176926A1 (en) | 1995-05-26 |
DE69433504T2 (de) | 2004-12-23 |
ATE258058T1 (de) | 2004-02-15 |
EP0734263A4 (de) | 1997-12-03 |
CA2176926C (en) | 2004-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE409864T1 (de) | Ss3-integrin als indikator für endometriose | |
IT1270130B (it) | Strumento diagnostico automatizzato in particolare per l'analisi di campioni in pacchi di prova per un analita | |
BR9902790A (pt) | Interface de usuário para um sistema analisador biomédico | |
DE69941366D1 (de) | ||
CA2230372A1 (en) | Quantitation of p97 to diagnose and monitor alzheimer's disease | |
ATE351921T1 (de) | Verfahren für fluoreszenzerkennungstest | |
BG104275A (en) | Method and device for express analysis of tested parameters in biological samples | |
ES2072279T3 (es) | Reactivos indicadores, ensayos de diagnostico y equipos de ensayo que utilizan particulas organicas de latex polimero. | |
HK1079568A1 (en) | A diagnostic reagent for cancer and a diagnostic kit for cancer, comprising an anti-gpc3 antibody | |
DE69522831D1 (de) | Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie | |
ATE96907T1 (de) | Verfahren und vorrichtung zum messen von abgaswerten bei kraftfahrzeugen. | |
CA2235316A1 (en) | A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd) | |
DE69019355D1 (de) | Verfahren und vorrichtung zum nachweis der nicht-triglyceride in ölen. | |
ATE23067T1 (de) | Verfahren und vorrichtung zur selbstueberpruefung von mikrorechnergesteuerten schaltgeraeten, insbesondere in kraftfahrzeugen. | |
CA2243444A1 (en) | Vehicle diagnosing apparatus | |
ATE156614T1 (de) | Verfahren und vorrichtung zum bestimmen, registrieren und fallweisen auswerten von betriebs- und/oder fahrdaten eines fahrzeuges | |
EP1052511A4 (de) | Verfahren zum testen der crohnschen krankheit und testkit dafür | |
CA2045353A1 (en) | Method and apparatus for measuring quantity of admixture in ready-mixed concrete | |
PL345608A1 (en) | Methodof immunologically measuring the content of human medullazine in blood and sclerosis multiplex diagnosing method based on such measurement | |
TW246718B (en) | Immunoassay for detecting HCV IgM antibody | |
JPS6474468A (en) | Testing device for integrated circuit | |
KR970015232A (ko) | 차량상태 진단방법 및 장치 | |
Chen | Review on Complexation | |
Johnson et al. | Soybean peroxidase assays | |
GB9616346D0 (en) | A specimen dilution indicator system for use in clinical diagnostic assays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |